Aptahem AB (XSAT:APTA) Cyclically Adjusted Book per Share: kr59.64 (As of Mar. 2026)


XSAT:APTA Aptahem AB XSAT:APTA
30 GF Score
Price kr0.58
! 2 Warning Signs
View Full Analysis

What is Aptahem AB Cyclically Adjusted Book per Share?

Aptahem AB XSAT:APTA +7.75% 30 Cyclically Adjusted Book per Share is kr59.64 as of Mar. 2026. GuruFocus rates XSAT:APTA with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Aptahem AB's adjusted book value per share for the three months ended in Mar. 2026 was kr3.056. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr59.64 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Aptahem AB's average Cyclically Adjusted Book Growth Rate was -15.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-06), Aptahem AB's current stock price is kr0.584. Aptahem AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr59.64. Aptahem AB's Cyclically Adjusted PB Ratio of today is 0.01.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Aptahem AB was 0.01. The lowest was 0.00. And the median was 0.00.


Aptahem AB  (XSAT:APTA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Aptahem AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.584/59.64
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Aptahem AB was 0.01. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Aptahem AB Cyclically Adjusted Book per Share Related Terms


Aptahem AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Aptahem AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aptahem AB Cyclically Adjusted Book per Share Chart

Aptahem AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 71.82 63.55

Aptahem AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.06 67.79 65.26 63.55 59.64

XSAT:APTA vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Aptahem AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptahem AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptahem AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Aptahem AB's Cyclically Adjusted PB Ratio falls into.


XSAT:APTA
30GF Score
Aptahem AB XSAT:APTA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aptahem AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Aptahem AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.056/133.5600*133.5600
=3.056

Current CPI (Mar. 2026) = 133.5600.

Aptahem AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 196.274 101.019 259.498
201609 185.259 101.138 244.649
201612 151.978 102.022 198.960
201703 138.185 102.022 180.903
201706 111.037 102.752 144.329
201709 95.459 103.279 123.447
201712 107.461 103.793 138.280
201803 96.007 103.962 123.340
201806 60.867 104.875 77.515
201809 46.123 105.679 58.292
201812 119.202 105.912 150.320
201903 40.914 105.886 51.607
201906 33.328 106.742 41.702
201909 24.750 107.214 30.832
201912 32.546 107.766 40.336
202003 28.428 106.563 35.630
202006 23.116 107.498 28.720
202009 17.006 107.635 21.102
202012 27.257 108.296 33.616
202103 14.426 108.360 17.781
202106 21.583 108.928 26.464
202109 35.635 110.338 43.135
202112 31.798 112.486 37.755
202203 30.656 114.825 35.658
202206 28.074 118.384 31.673
202209 27.086 122.296 29.581
202212 25.924 126.365 27.400
202303 24.773 127.042 26.044
202306 26.161 129.407 27.001
202309 22.200 130.224 22.769
202312 20.574 131.912 20.831
202403 12.496 132.205 12.624
202406 10.090 132.716 10.154
202409 9.901 132.304 9.995
202412 5.037 132.987 5.059
202503 4.902 132.825 4.929
202506 3.662 133.699 3.658
202509 3.907 133.480 3.909
202512 3.121 133.390 3.125
202603 3.056 133.560 3.056

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr59.64 mean?
Aptahem AB (XSAT:APTA) has a Cyclically Adjusted Book per Share of kr59.64 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Aptahem AB and its competitors.
Is Aptahem AB's Cyclically Adjusted Book per Share too high?
Aptahem AB's current Cyclically Adjusted Book per Share is kr59.64. Overall, Aptahem AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Aptahem AB's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Aptahem AB's Cyclically Adjusted Book per Share of kr59.64 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Aptahem AB and its competitors. Aptahem AB's current Cyclically Adjusted Book per Share is kr59.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptahem AB stock overvalued right now?
Aptahem AB (XSAT:APTA) has a current Cyclically Adjusted Book per Share of kr59.64. The current Cyclically Adjusted Book per Share is kr59.64. Aptahem AB's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Aptahem AB (XSAT:APTA), the current Cyclically Adjusted Book per Share is kr59.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aptahem AB Business Description

Address Norra Vallgatan 58, Malmo, SWE, 211 22
Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.
30GF Score

Get the complete analysis for XSAT:APTA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.58
Price